ניוזלטר של האגודה הישראלית לאנדוקרינולוגיה | ספטמבר 2014

תאריך: 07/09/2014

גליון מס' 16

ספטמבר 2014

" I have not failed. I've just found 10,000 ways that won't work."
Thomas A. Edison (1847-1931)

חברי האגודה שלום,

השנה האקדמית מתחילה ואנו חוזרים לשגרה. בחוברת ספטמבר הודעת ועד האגודה על פרסים ומלגות חדשים וגם שינויים בגובה מלגות למציגים עבודה בכנס בינלאומי. בנוסף תמצאו בחוברת זו עדכונים, חדשות ומאמרים חשובים כמו כל חודש, וכן רשימת מפגשים עתידיים. צפייה מהנה

חדשות וועד האגודה

מלגות ופרסים של האגודה האנדוקרינית

על פי התקציב שברשות האגודה לשנים הקרובות, הוחלט להגביר את התמיכה לפעילות אקדמית כדלקמן:

1) להעניק שתי מלגות מחקר פעם בשנה לחוקרים צעירים, בתחומים קליניים או בסיסים בסך
40,000 ₪ כ"א. קריטריונים ומועדי הגשת בקשות יפרסמו באתר. לפרטים נוספים אפשר
לפנות למזכירת האגודה דר' נחמה צוקרמן-לוין.

2) להעלות את סכום התמיכה לחוקרים צעירים המציגים את עבודתם בכנס בינלאומי (3,500 ש"ח באירופה ו- 5,000 ש"ח בארה"ב). השינויים יכנסו לתוקף כבר במועד הקרוב, נובמבר 2014.

3) הוקם פרס למתמחים/דוקטורנטים המסיימים את ההתמחות או PhD בהצטיינות. הפרס הוא תמיכה
כספית של 5,000 ₪ למטרת השתתפות בכנס האנדוקריני של האיגוד האמריקני או האירופאי ויוענק
לפי קריטריונים שיקבעו על ידי ועד האגודה ויו"ר ועדת הבחינות מעת לעת. אנו סבורים שחשיפה
לפורום מדעי בינלאומי מעין אלו יחזק את השאיפה להמשיך ולפתח קריירה בתחום אקדמי זה.

כנס החורף של האגודה האנדוקרינית

ועד האגודה מקדם את ארגון כנס החורף ברשותו של פרופ' קרסיק.
הכנס יתקיים באילת בתאריך 27-29/11/2014, אנא שריינו ביומנים
תוכנית הכנס תתפרסם בקרוב.
פרטים נוספים יעודכנו בלינק הבא

הר"י: עדכונים למתמחים

מידע למתמחים על מבחני ההתמחות בלינק הבא

אירועים וכנסים בארץ ובחו"ל

Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism
ב 19-21/9/13 התקיים Workshop on Asymptomatic Hyperparthyroidism בפירנזה, איטליה, עם מיטב המומחים בתחום. פרוטוקולים וסיכומי המפגש התפרסמו החודש ב JCEM ahead of print.
בלינק הבא

רשימת מפגשים וכנסים קרובים

ב 06/09/14 – כנס שנתי European Thyroid Association (Spain)
ב 12/09/14 – כנס שנתי ASBMR (Houston, USA)
ב 15/09/14 – כנס שנתי EASD (Vienna, Austria)
ב 18/09/14 – כנס שנתי ESPE (Dublin, Ireland)
ב 15/10/14 – כנס שנתי GH & IGF society (Signapore)
ב 22/10/14 – 2nd Course on Neuroendocrine Tumors (הדסה)
ב 23/10/14 – כנס EndoBridge 2014 (Antalya, Turkey)
ב 26/10/14 – פורום סרטן בלוטת התריס (סורוקה)

חדשות באנדוקרינולוגיה

FDA Approves Empagliflozin For Type 2 Diabetes.
The FDA has approved Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin) type 2 diabetes treatment. Earlier this year, Lilly and Boehringer said the FDA didn’t approve the drug because of concerns about the Boehringer factory in Germany where it will be made. The FDA recommended that Jardiance be used along with lifestyle changes but it can be added to existing treatment to control diabetes
להמשך קריאה

Vitamin D Deficiency Tied To Increased Risk Of Alzheimer’s, Dementia.
In an article published in Neurology researchers studied vitamin D levels in 1,658 people age 65 and older who were able to walk, free of dementia, and without a history of cardiovascular disease or stroke. For the next six years, medical personnel tracked the subjects using brain scans, cognitive tests, medical records and other diagnostic tools, to see how many developed Alzheimer’s disease or other forms of dementia. They found that adults who suffered from a moderate D deficiency had a 53% higher risk of some form of dementia, while the risk increased 125% in those with severe deficiencies.
להמשך קריאה

Pfizer Facing Wave Of Lawsuits Over Anti-Cholesterol Treatment.
According to a review conducted by Reuters of lawsuits filed in Federal court, there are now nearly 1,000 lawsuits filed against Pfizer by women alleging that they developed type 2 diabetes after taking its anti-cholesterol medication Lipitor .
להמשך קריאה

Researchers accuse JAMA of ethics violations over testosterone study.
The Androgen Study Group has written to the Journal Oversight Committee of the JAMA regarding a study that linked testosterone with cardiovascular risks which they believe should have been retracted following corrections and other problems with the data. The letter says JAMA violated accepted standards of medical journal ethics and editorial integrity and has enormous responsibility for unfounded concerns among millions of men treated appropriately for testosterone deficiency which have prompted many men to discontinue treatment even among those who had clearly benefited.
להמשך קריאה

Growth Hormone For Children May Raise Risk Of Stroke.
A study published in Neurology reports that among a group of children treated for short stature or low levels of growth hormone had between a 1.5 to 5.3 times higher risk of having a stroke during the follow-up period than the general population.
להמשך קריאה

Endocrine Society Statement on Possible Association Between GH Therapy in Childhood and Later Stroke
להמשך קריאה

Exposure To Phthalates May Reduce Testosterone In Men, Women, And Children.
A research in JCEM suggests exposure to phthalates, chemicals commonly found in plastics and personal care products, may reduce testosterone levels in men, women, and children. Investigators came to this conclusion after conducting a cross-sectional study using data from the U.S. NHANES for 2011 to 2012 aiming to assess the association between urinary phthalate metabolites and testosterone in men, women, and children.
להמשך קריאה

FDA Grants Tentative Approval To Insulin Glargine Injection.
Eli Lilly & Co. and Boehringer Ingelheim received tentative approval from the FDA for its Basaglar (insulin glargine) injection for diabetes patients. However, the medication still has to pass some legal steps because a case filed by Sanofi SA, which claims Eli Lilly infringes seven patents related to insulin and devices to deliver Basaglar,
להמשך קריאה

FDA Approves Test To Distinguish Type 1 Diabetes From Other Types.
FDA disclosed giving green light to first autoantibody test that can distinguish type 1 diabetes from other kinds. The approval is for Kronus’ Zinc Transporter 8 Autoantibody (ZnT8Ab) assay, which can detect the ZnT8 antibody in blood. Only people with type 1 diabetes produce the antibody. The article notes that if type 1 diabetes is detected earlier, patients can start the treatment before further loss of insulin-producing beta cells.
להמשך קריאה

פינת האומנות וההיסטוריה

And the lights turned on
Thomas Edison born in 1847 in Milan, Ohio, grew up in Port Huron, Michigan. He developed hearing problems at an early age and ended just three months of official schooling. His mother taught him at home. Edison sold candy and newspapers on trains and later set in type and printed the Grand Trunk Herald. This began Edison's long streak of entrepreneurial ventures, that eventually led him to found 14 companies, including General Electric. He married twice and have three childreen each time. The invention that first gained him notice was the Phonograph in 1877 as he travelled to Washington to present it before the National Academy of Sciences, Congressmen, Senators and US President. His major innovation was Menlo Park, the first industrial research lab built in New Jersey with funds from the sale of Edison's quadruplex Telegraph. After his demonstration of the telegraph, Edison was not sure his original plan to sell it for $5,000 was right, so he asked Western Union to make a bid. He was surprised to hear them offer $10,000 which he gratefully accepted. In 1877, Edison invented and developed the carbon Microphone used in all telephones along with the Bell receiver until the 1980s. While Edison did not invent the first electric light bulb, he invented the first commercially practical incandescent light and the first successful test in 1879 lasted 13.5 hours. He filed for U.S. patent for the Electric Lamp using a carbon filament or strip coiled and connected to platina contact wires, and in 1878 funded the Edison Electric Light Company in New York. It was during this time that he said: "We will make electricity so cheap that only the rich will burn candles”. Edison patented a system for electricity distribution in 1880 when he found the Edison Illuminating Company. It was on September 4, 1882, that Edison switched-on his Pearl Street generating station's electrical power distribution system, which provided 110 volts direct current (DC) to 59 customers in lower Manhattan. In 1887, there were 121 Edison power stations in the United States delivering DC electricity to customers. AC (Westinghouse) replaced DC in most instances, enormously extending the range and improving the efficiency of power distribution. There were still 1,600 DC customers in New York City as of 2005, and service was finally discontinued in 2007. Most subway systems are still powered by direct current. In 1891, Edison built a Kinetoscope, or peep-hole viewer. This device was installed in penny arcades, where people could watch short, simple films. In April 1896, Thomas Armat's Vitascope, manufactured by Edison factory and marketed in Edison's name, was used to project motion pictures in public screenings in New York. Later he exhibited motion pictures with voice soundtrack mechanically synchronized with the film. Edison is also credited with designing and producing the first commercially available Fluoroscope, a machine that uses X-rays to take radiographs. Until Edison discovered that calcium tungstate fluoroscopy screens produced brighter images than the barium platinocyanide screens used by Wilhelm Röntgen, the technology was capable of producing only very faint images. In 1892 Edison General Electric, merged with Thomson-Houston Electric Company to form General Electric. In 1908, Edison started the Motion Picture Patents Company, which was a conglomerate of nine major film studios. In 1927, Eddison was granted membership in the National Academy of Sciences and in 1929 became the first honorary fellow of the Acoustical Society of America. Edison died of complications of diabetes inNew Jersey in 1931 and is buried behind his home.

מקורות: וויקיפדיה

להתראות בגיליון הבא !

עורך: דר' קרלוס בן בסט

carlosb@netvision.net.il

עכשיו בחדשות:

ניוזלטר של האגודה הישראלית לאנדוקרינולוגיה | ספטמבר 2014

מלגות ופרסים של האגודה האנדוקרינית

כנס החורף של האגודה האנדוקרינית

הר"י: עדכונים למתמחים

רשימת מפגשים וכנסים קרובים

ברוכים הבאים לאתר האגודה הישראלית לאנדוקרינולוגיה